NextMSC News
Category
Pharmaceutical Drug Delivery Market: Lilly Phase 3 Data
Lilly Reports Retatrutide Outperformed Ozempic in 80-Week Phase 3 Type 2 Diabetes Trial INDIANAPOLIS, United States — October 28, 2026 — Eli Lilly and Company announced positive topline results fro... Read News
Published date : October 29, 2026
Parkinson’s Diagnostics Industry Tracks Blood Sensor Data
KAUST and Oxford Researchers Report Blood Sensor Detecting Three Alpha-Synuclein Forms in 40 Minutes OXFORD, United Kingdom — October 15, 2026 — Researchers at King Abdullah University of Science a... Read News
Published date : October 27, 2026
Quarterly Antibiotics Market Update: Q4 2026
Chinese Antibiotic Competition Puts Europe’s Penicillin Supply Chain in Focus Sandoz is seeking anti-dumping measures amid competition from lower-priced Chinese antibiotics and ingredients, accord... Read News
Published date : October 23, 2026
AstraZeneca–Insitro AI Deal Reshapes Drug Discovery
AstraZeneca Signs $40M AI Drug Discovery Deal With Insitro for MASH and Heart Disease LONDON, United Kingdom October 15, 2026 AstraZeneca has entered into a multi-year collaboration with Californi... Read News
Published date : October 15, 2026
FDA Validation and Pharma Deals Push AI Drug Discovery Into the Mainstream
FDA's In Silico Validation Mandate and Insilico Medicine's $7.3B Deal Surge Signal a Structural Shift in Computational Drug Discovery In the span of eight months, two events have fundamentally alte... Read News
Published date : October 13, 2026
Roche's $1.16B RNAi Deal Signals Biopharmaceutical Market Shift
Roche Signs $1.16 Billion RNAi Licensing Deal With China's Rona Therapeutics for Obesity Drug ZURICH, Switzerland — October 13, 2026 — Swiss drugmaker Roche has entered a licensing agreement worth... Read News
Published date : October 13, 2026
AI and Virtual Biology Reshape In-Silico Drug Discovery
ARDD 2026: Frontier AI and Big Pharma Converge at Harvard to Redefine Longevity Drug Discovery CAMBRIDGE, Massachusetts, United States — October 12, 2026 — Frontier artificial intelligence, large-... Read News
Published date : October 11, 2026
Beta Bionics' Mint FDA Clearance Signals Smarter Insulin Delivery | NextMSC
Beta Bionics' Mint Patch Pump FDA Clearance Signals a New Era for Intelligent Insulin Delivery Devices On September 14, 2026, Beta Bionics, Inc. (Nasdaq: BBNX) announced U.S. Food and Drug Administ... Read News
Published date : October 2, 2026
Novo Nordisk-Nanexa €1.17B Drug Delivery Devices Deal
Novo Nordisk Signs €1.17B Pact with Nanexa for Long-Acting Injectable Drug Delivery Tech STOCKHOLM, Sweden September 28, 2026 Novo Nordisk (NYSE: NVO) has entered into a global licensing agreement... Read News
Published date : September 28, 2026
GLP-1 Demand Surge Reshapes Biologicals Market
GLP-1 Use Hits Record 11% of US Adults as Medicare Bridge Program Expands Access WASHINGTON, D.C., United States July 8, 2026, the share of U.S. adults using GLP-1 receptor agonist medications for... Read News
Published date : September 24, 2026
